Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name BLACAT1
   Synonyms BLACAT1, LINC00912, UBC1, onco-lncRNA-30, linc-UBC1, onco-lncRNA-30
   Region GRCh38_1:205434886-205437879    Sequence
   Ensembl ENSG00000281406
   RefSeq NR_103783
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name cervical cancer
   ICD-0-3 C53  
   Methods qPCR, Western blot, in vitro knockdown
   Sample cervical cancer tissues, Cervical cancer cell lines (Siha,CaSki, Hela, ME180 and C33A)
   Expression Pattern up-regulated
   Function Description

BLACAT1 was highly expressed in human cervical cancer tissues and cell lines. The knockdown of BLACAT1 with specific short hairpin RNA reduced colony formation rates in ME180 and C33A cells. Cell cycle and cell proliferation assays revealed that depletion of BLACAT1 in ME180, and C33A cells arrested the cell cycle at the G0/G1 phase and inhibited cell proliferation. Transwell assays demonstrated that the knockdown of BLACAT1 inhibited cell migration and invasion in ME180,and C33A cells. Moreover, wound-healing assays supportedthe aformentioned observations. Western blot analysis showed that the knockdown of BLACAT1 in ME180 and C33A cells decreased the protein levels of cyclin B1, cell division cycle 25C, and N-cadherin, while increasing the protein level of E-cadherin.

   Pubmed ID 29456724
   Year 2018
   Title Long noncoding RNA BLACAT1 promotes cell proliferation and invasion in human cervical cancer.
   External Links
   Links for  BLACAT1 GenBank       HGNC       lncrnadb       Noncode
   Links for  cervical cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.